Literature DB >> 7979976

Vaccinia virus expression of the VP7 protein of South African bluetongue virus serotype 4 and its use as an antigen in a capture ELISA.

M Cloete1, D H du Plessis, A A van Dijk, H Huismans, G J Viljoen.   

Abstract

Recombinant vaccinia viruses expressing the VP7 core protein of South African bluetongue virus serotype 4 (SA-BTV4) were identified by polymerase chain reaction amplification. Expression of VP7 was verified by radio-immunoprecipitation and a F(ab')2-based ELISA. Antibodies to VP7 were detected in sera from sheep that had been infected with 20 different virulent BTV serotypes by using the vaccinia virus (VV) expressed VP7 as antigen in a capture ELISA. F(ab')2-immobilised VV-expressed SA-BTV4 VP7 cross-reacted with sera directed against all 9 African horsesickness virus serotypes and epizootic haemorrhagic disease virus serotype 2.

Entities:  

Mesh:

Substances:

Year:  1994        PMID: 7979976     DOI: 10.1007/BF01310024

Source DB:  PubMed          Journal:  Arch Virol        ISSN: 0304-8608            Impact factor:   2.574


  34 in total

1.  Three-dimensional structure of single-shelled bluetongue virus.

Authors:  B V Prasad; S Yamaguchi; P Roy
Journal:  J Virol       Date:  1992-04       Impact factor: 5.103

2.  Isolation of a capsid protein of bluetongue virus that induces a protective immune response in sheep.

Authors:  H Huismans; N T van der Walt; M Cloete; B J Erasmus
Journal:  Virology       Date:  1987-03       Impact factor: 3.616

3.  Cleavage of structural proteins during the assembly of the head of bacteriophage T4.

Authors:  U K Laemmli
Journal:  Nature       Date:  1970-08-15       Impact factor: 49.962

4.  Direct hybridization of labeled DNA to DNA in agarose gels.

Authors:  M Purrello; I Balazs
Journal:  Anal Biochem       Date:  1983-02-01       Impact factor: 3.365

5.  Purification and characterization of the major group-specific core antigen VP7 of bluetongue virus synthesized by a recombinant baculovirus.

Authors:  S Oldfield; A Adachi; T Urakawa; T Hirasawa; P Roy
Journal:  J Gen Virol       Date:  1990-11       Impact factor: 3.891

6.  Vaccinia virus: a selectable eukaryotic cloning and expression vector.

Authors:  M Mackett; G L Smith; B Moss
Journal:  Proc Natl Acad Sci U S A       Date:  1982-12       Impact factor: 11.205

7.  Characterization of the genes encoding two of the major capsid proteins of epizootic haemorrhagic disease virus indicates a close genetic relationship to bluetongue virus.

Authors:  H Iwata; T Chuma; P Roy
Journal:  J Gen Virol       Date:  1992-04       Impact factor: 3.891

8.  Identification of the serotype-specific and group-specific antigens of bluetongue virus.

Authors:  H Huismans; B J Erasmus
Journal:  Onderstepoort J Vet Res       Date:  1981-06       Impact factor: 1.792

9.  Alteration in antibody reactivity with foot-and-mouth disease virus (FMDV) 146S antigen before and after binding to a solid phase or complexing with specific antibody.

Authors:  K C McCullough; J R Crowther; R N Butcher
Journal:  J Immunol Methods       Date:  1985-09-03       Impact factor: 2.303

10.  Purification of the group-specific antigen of bluetongue virus by chromatofocusing.

Authors:  O J Hübschle; C Yang
Journal:  J Virol Methods       Date:  1983-03       Impact factor: 2.014

View more
  1 in total

1.  Antigen capture competitive enzyme-linked immunosorbent assays using baculovirus-expressed antigens for diagnosis of bluetongue virus and epizootic hemorrhagic disease virus.

Authors:  J O Mecham; W C Wilson
Journal:  J Clin Microbiol       Date:  2004-02       Impact factor: 5.948

  1 in total

北京卡尤迪生物科技股份有限公司 © 2022-2023.